跳至主要内容
临床试验/IRCT2016100930224N1
IRCT2016100930224N1招募中2 期

Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema

Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
9 years 至 47 years(—)
性别
All

入选标准

  • patients with inactive uveitis, according to sun group classification, who had visual loss due to macular edema (diagnosed by optical coherence tomography (OCT)) and not responding to topical medication such as steroid.
  • Exclusion criteria included any other ophthalmic disease that causes macular edema (e.g. diabetes, venous occlusive diseases); any intraocular surgery within 3 months of injection; media opacity that hinders assessment of macula by OCT, prior vitrectomy; Glaucoma; ocular hypertension and monocularity.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shiraz University of Medical Sciences

相似试验

Comparison of intravitreal anti-VEGF drug and... | 临床试验